Our Tests

Home

Laboratory Services

Our Tests

Contact Us

All
Common Tests
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Bone Marrow culture
Other Names: 5800
Methods: Karyotyping
TAT: 21 Days
Dept: Cyto
Specimen 01: Bone Marrow
Container 01: Sodium Heparin
Description: For Numerical & Structural Chromosomal Abnormalities.
Bone Profile (Ca/Phos/Prot/Alb/ALP)
Other Names: 1365
Methods: Spectrophotometry
TAT: Same Day
Dept: Bio
Specimen 01: Serum
Container 01: Plain
Description: Assessment of bone related diseases (Calcium, Phosphorus, Protein (Total), Albumin, Alkaline Phosphatase)
Brucella Agglutination
Other Names: 8836
Methods:
TAT:
Dept:
Brucella Agglutination
Other Names: 8836
Methods: Latex Agglutination
TAT: 24 Hours
Dept: Sero
Specimen 01: Serum
Container 01: Plain
Description: Screening test for Brucellosis.
C-ANCA (PR-3)
Other Names: 1862CCG
Methods: ELISA-Enzyme Linked Immunosrbent Assay
TAT: Within 07 Days
Dept: Sero
Specimen 01: Serum
Container 01: Plain
Description: Diagnosis of autoimmune vasculitis
C-Peptide
Other Names: 3140
Methods: Electrochemiluminescence
TAT: Thursday
Dept: Bio
Specimen 01: Serum
Container 01: Plain
Description: Diagnostic workup of Hypoglycemia, evaluation of possible tumors od cell which secretes insulin.
C3
Other Names: 1501D - Complement 3 (C3)
Methods: Immunoturbidimetry
TAT: Mon/Fri
Dept: Bio
Specimen 01: Serum
Container 01: Plain
Description: "Assessing disease activity in SLE. rheumatoid arthritis, subacute bacterial endocarditis, viremia, parasitic infections or bacterial sepsis. A considerable decrease in C3 can be found in patients with partial lipodystrophy or membranoproliferative glomerulonephritis when the C3‑nephritis factor is present."
CA 15.3
Other Names: 3134
Methods: Electrochemiluminescence
TAT: Monday
Dept: Bio
Specimen 01: Serum
Container 01: Plain
Description: Useful for monitoring patients with Breast cancer.
CA 19.9
Other Names: 3120
Methods: Electrochemiluminescence
TAT: Monday
Dept: Bio
Specimen 01: Serum
Container 01: Plain
Description: Evaluating and Monitoring Pancreatic tumors.
1 38 39 40 41 42 96